PENICILLAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Penicillamine, and what generic alternatives are available?
Penicillamine is a drug marketed by Apotex, Breckenridge, Dr Reddys, Granules, Invagen Pharms, Navinta Llc, Ph Health, Watson Labs Inc, Lupin, and Teva Pharms Usa. and is included in eleven NDAs.
The generic ingredient in PENICILLAMINE is penicillamine. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillamine
A generic version of PENICILLAMINE was approved as penicillamine by WATSON LABS INC on June 24th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENICILLAMINE?
- What are the global sales for PENICILLAMINE?
- What is Average Wholesale Price for PENICILLAMINE?
Summary for PENICILLAMINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 19 |
| Patent Applications: | 4,278 |
| Drug Prices: | Drug price information for PENICILLAMINE |
| What excipients (inactive ingredients) are in PENICILLAMINE? | PENICILLAMINE excipients list |
| DailyMed Link: | PENICILLAMINE at DailyMed |
Recent Clinical Trials for PENICILLAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Muhammad Zark | PHASE2 |
| Nanfang Hospital, Southern Medical University | Phase 2 |
| Narowal Medical College | NA |
Pharmacology for PENICILLAMINE
| Drug Class | Antirheumatic Agent |
Medical Subject Heading (MeSH) Categories for PENICILLAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PENICILLAMINE
US Patents and Regulatory Information for PENICILLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 213310-001 | Apr 28, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ph Health | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 211231-001 | Dec 23, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Granules | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 211735-001 | Dec 2, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs Inc | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 210976-001 | Jun 24, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Breckenridge | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 215409-001 | Aug 23, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
